MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 03-09-2026
Anixa Biosciences DIO Ratio 2011-2026 | ANIX
Quarterly DIO Ratio Anixa Biosciences
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.54 | 1.39 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.39 | 0.54 | 0.965 |
DIO Ratio of other stocks in the Diagnostics research industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
25.4 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Co-Diagnostics
CODX
|
1.69 K | $ 1.6 | -3.03 % | $ 2.13 M |  USA |
 |
Agilent Technologies
A
|
97.1 | $ 114.83 | -0.68 % | $ 34.9 B | USA |
 |
Accelerate Diagnostics
AXDX
|
198 | - | -61.36 % | $ 2.46 M | USA |
 |
Chembio Diagnostics
CEMI
|
97.6 | - | 0.22 % | $ 16.8 M | USA |
 |
Aspira Women's Health
AWH
|
32.2 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
21.9 | - | -13.05 % | $ 7.29 M | USA |
 |
Castle Biosciences
CSTL
|
48.7 | $ 24.69 | -1.18 % | $ 686 M | USA |
 |
Enzo Biochem
ENZ
|
156 | - | -8.98 % | $ 14.8 K | USA |
 |
Illumina
ILMN
|
137 | $ 126.51 | -1.57 % | $ 20.1 B | USA |
 |
CareDx, Inc
CDNA
|
48.3 | $ 21.98 | 0.59 % | $ 1.17 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
210 | - | - | $ 562 M |  Britain |
 |
DermTech
DMTK
|
33.5 | - | -11.32 % | $ 2.94 M | USA |
 |
Exact Sciences Corporation
EXAS
|
60.9 | - | - | $ 19.8 B | USA |
 |
Lantheus Holdings
LNTH
|
40.4 | $ 83.3 | -0.97 % | $ 5.62 B | USA |
 |
Fulgent Genetics
FLGT
|
7.17 | $ 15.33 | -1.73 % | $ 464 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
116 | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
89.7 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
131 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
42.1 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
62.8 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
35.3 | $ 165.87 | -3.13 % | $ 8.22 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
89 | $ 27.05 | -1.78 % | $ 20 B |  Niderland |
 |
Guardant Health
GH
|
82.1 | $ 82.95 | -6.27 % | $ 10.4 B | USA |
 |
Precipio
PRPO
|
22.7 | $ 31.65 | 3.09 % | $ 50.8 M | USA |
 |
Personalis
PSNL
|
12.1 | $ 5.5 | -7.75 % | $ 326 M | USA |
 |
Heska Corporation
HSKA
|
137 | - | - | $ 1.31 B | USA |
 |
Interpace Biosciences
IDXG
|
29.1 | $ 1.93 | - | $ 8.54 M | USA |
 |
Senseonics Holdings
SENS
|
104 | $ 7.17 | -1.44 % | $ 299 M | USA |
 |
QIAGEN N.V.
QGEN
|
141 | - | - | $ 10.6 B | Niderland |
 |
Motus GI Holdings
MOTS
|
3.37 K | - | -34.28 % | $ 263 K |  Israel |
 |
Biomerica
BMRA
|
147 | $ 2.19 | 0.46 % | $ 5.03 M | USA |
 |
ICON Public Limited Company
ICLR
|
0.213 | $ 101.98 | -1.19 % | $ 8.41 B |  Irlanda |
 |
Thermo Fisher Scientific
TMO
|
86.5 | $ 471.36 | 0.71 % | $ 178 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
18.9 | $ 260.02 | -1.29 % | $ 21.6 B | USA |
 |
Trinity Biotech plc
TRIB
|
212 | $ 0.61 | -5.2 % | $ 61.9 M | Irlanda |
 |
Neogen Corporation
NEOG
|
147 | $ 9.24 | -2.22 % | $ 2 B | USA |
 |
Twist Bioscience Corporation
TWST
|
51.5 | $ 59.61 | -2.2 % | $ 3.57 B | USA |
 |
NeoGenomics
NEO
|
24.4 | $ 8.97 | 4.17 % | $ 1.15 B | USA |
 |
Myriad Genetics
MYGN
|
42.8 | $ 4.88 | 0.93 % | $ 452 M | USA |
 |
Natera
NTRA
|
25.8 | $ 200.99 | -1.67 % | $ 19.8 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
9.34 | $ 194.95 | -0.85 % | $ 21.6 B | USA |
 |
Invitae Corporation
NVTA
|
126 | - | - | $ 21.2 M | USA |
 |
OpGen
OPGN
|
459 | - | -16.95 % | $ 1.54 M | USA |